Rice Flour Noodles That Boost Satiety Hormones GLP-1 and PYY While Lowering Blood Sugar
Noodles made with 30% RD43 rice flour significantly increased GLP-1 and PYY hormone levels while reducing blood sugar and appetite in humans.
Quick Facts
What This Study Found
Noodles prepared with 30% RD43 rice flour substitution significantly lowered postprandial plasma glucose at 15–90 minutes compared to control noodles. At the same time, the modified noodles significantly increased circulating levels of two key satiety peptide hormones — GLP-1 (glucagon-like peptide-1) and PYY (peptide tyrosine-tyrosine) — at 30 minutes after consumption.
Participants also reported significantly lower desire to eat and higher fullness lasting up to 120 minutes after consuming the RD43 rice noodles. The food science analysis showed that increasing RD43 rice flour content from 10–40% progressively reduced starch digestibility and rapidly digestible starch while increasing undigestible starch. Importantly, the 30% substitution level maintained similar overall sensory acceptability to conventional noodles.
Key Numbers
30% RD43 rice flour; GLP-1 and PYY increased at 30 min; glucose lower at 15-90 min; desire to eat decreased and fullness increased until 120 min; similar overall acceptability
How They Did This
This was a combined food science and human crossover study. Researchers first developed noodles with 10–40% RD43 rice flour substitution and characterized their starch digestibility, physicochemical properties, and sensory attributes. They then conducted a human meal test comparing 30% RD43 rice noodles against control noodles, measuring postprandial blood glucose, GLP-1, PYY, and subjective appetite ratings over time.
Why This Research Matters
Finding ways to naturally stimulate the body's own satiety hormones through everyday foods — rather than injectable drugs — could offer a practical, population-level approach to managing blood sugar and controlling appetite. This is especially relevant given the growing interest in GLP-1 as a therapeutic target for diabetes and obesity.
The Bigger Picture
GLP-1 receptor agonists like semaglutide have revolutionized diabetes and obesity treatment, but they require injections and can be expensive. This study explores the other side of the equation — whether modifying common foods can naturally boost the body's own GLP-1 and PYY production. While the effects are modest compared to pharmaceutical GLP-1RAs, food-based approaches could complement drug therapy or serve as preventive strategies for at-risk populations.
What This Study Doesn't Tell Us
The sample size for the human study was not specified in the abstract, so the statistical power is unclear. This was an acute single-meal test, not a long-term dietary intervention, so it's unknown whether the effects persist with regular consumption. Only one rice variety (RD43) was tested, and cultural food preferences may limit how widely rice flour noodles could be adopted outside Asian populations.
Questions This Raises
- ?Would regular daily consumption of RD43 rice flour noodles produce sustained improvements in appetite control and blood sugar management over weeks or months?
- ?How do the magnitudes of GLP-1 and PYY increases from these noodles compare to those from pharmaceutical GLP-1 receptor agonists?
- ?Could this approach be applied to other staple foods beyond noodles, such as bread or rice dishes?
Trust & Context
- Key Stat:
- GLP-1 & PYY up at 30 min Both satiety peptide hormones were significantly elevated 30 minutes after eating rice flour noodles, alongside lower blood sugar at 15–90 minutes.
- Evidence Grade:
- This is a moderate-evidence study combining food characterization with a human crossover trial. While the crossover design is a strength, the unspecified sample size and acute (single-meal) nature of the human component limit the strength of conclusions about long-term effects.
- Study Age:
- Published in 2021, this study is relatively recent and aligns with the growing interest in food-based approaches to modulating GLP-1 and other gut peptide hormones.
- Original Title:
- RD43 rice flour: the effect on starch digestibility and quality of noodles, glycemic response, short-acting satiety hormones and appetite control in humans.
- Published In:
- Food & function, 12(17), 7975-7985 (2021)
- Database ID:
- RPEP-05796
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
How do RD43 rice flour noodles affect satiety hormones?
Eating noodles made with 30% RD43 rice flour significantly increased levels of GLP-1 and PYY — two peptide hormones that signal fullness to the brain — at 30 minutes after the meal. Participants also reported feeling fuller and less hungry for up to two hours.
Do the modified noodles taste different from regular noodles?
According to the study, noodles with 30% RD43 rice flour had similar overall acceptability to conventional wheat noodles, though they were slightly lighter in color and less hard in texture.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05796APA
Suklaew, Phim On; Chusak, Charoonsri; Wang, Chin-Kun; Adisakwattana, Sirichai. (2021). RD43 rice flour: the effect on starch digestibility and quality of noodles, glycemic response, short-acting satiety hormones and appetite control in humans.. Food & function, 12(17), 7975-7985. https://doi.org/10.1039/d1fo01389k
MLA
Suklaew, Phim On, et al. "RD43 rice flour: the effect on starch digestibility and quality of noodles, glycemic response, short-acting satiety hormones and appetite control in humans.." Food & function, 2021. https://doi.org/10.1039/d1fo01389k
RethinkPeptides
RethinkPeptides Research Database. "RD43 rice flour: the effect on starch digestibility and qual..." RPEP-05796. Retrieved from https://rethinkpeptides.com/research/suklaew-2021-rd43-rice-flour-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.